2-127307698-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001371910.2(MAP3K2):āc.1741A>Gā(p.Lys581Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,597,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001371910.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K2 | NM_001371910.2 | c.1741A>G | p.Lys581Glu | missense_variant | 17/17 | ENST00000682094.1 | NP_001358839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K2 | ENST00000682094.1 | c.1741A>G | p.Lys581Glu | missense_variant | 17/17 | NM_001371910.2 | ENSP00000507315.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000903 AC: 2AN: 221428Hom.: 0 AF XY: 0.00000838 AC XY: 1AN XY: 119298
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1444820Hom.: 0 Cov.: 31 AF XY: 0.00000419 AC XY: 3AN XY: 716820
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.1741A>G (p.K581E) alteration is located in exon 16 (coding exon 16) of the MAP3K2 gene. This alteration results from a A to G substitution at nucleotide position 1741, causing the lysine (K) at amino acid position 581 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at